3
2
1

World first! Collaborative team of Shandong Yinfeng Life Science Institution implements intra-operative dual-activated ovarian technology

Release time:

2024-06-17

In collaboration with the team of Huiying Wang and Bo Jin from the Department of Reproductive Health Medicine, Shenzhen Hospital, Beijing University of Chinese Medicine, the Cryomedicine Center of Shandong Yinfeng Life Science Institution has made significant progress by focusing on the research, development and clinical application of original technologies for assisted reproduction and fertility preservation.
In October 2023, during a laparoscopic surgery at the hospital, a 34-year-old amenorrheic female patient's menstruation was restored to normal by freezing ovarian tissue + PFC dual-activated ovarian technology. The patient has been followed up for 7 months, and her AMH has improved from 0.06 ng/ml preoperatively to 0.21 ng/ml postoperatively, FSH: 4.8 mIU/ml, with normal follicular development in both ovaries. This is the first case in the world of normal follicular development in both ovaries using the dual-activated ovarian technology.

Latest developments

The theme publicity activity of "Central Media Look at Jinan - Entering Jinan's Private Economy" was held in Yinfeng Biotechnology Park

On August 23, the Jinan Private Economic Development Bureau and China Economic Weekly jointly launched the theme publicity activity of "Central Media Look at Jinan - Entering Jinan's Private Economy" in Yinfeng Biotechnology Park.

Yinfeng Cryogenic and Anhui Medical University "Ministry of Education Engineering Research Center" project was accepted and awarded by the Ministry of Education

Led by Anhui Medical University and participated by Yinfeng Cryogenic Medical Technology Co., Ltd., the "Engineering Research Center for Life Resources Conservation and Artificial Organs of the Ministry of Education" was officially accepted and awarded by the Ministry of Education. As one of the four major platforms for the transformation of the center's project, Yinfeng Cryogenic Co., Ltd. is responsible for the "development, promotion and application of cryogenic preservation technology of biological matrix materials".

The inaugural meeting of the International Alliance for Life Extension Research was successfully concluded

On March 28, 2023, the kick-off meeting of the International Alliance for Life Extension Research was held in Jinan, Shandong. The "International Alliance for Life Extension Research" was initiated by Shandong Yinfeng Life Science Research Institute, and jointly established by 13 international scientific research institutions engaged in the field of cryogenic biomedicine from North America, Europe, Oceania, etc., and appeared at the conference through online and offline forms.